Is lapatinib available in domestic hospitals?

Lapatinib (Lapatinib) is a drug used to treat cancer. It was originally developed by GlaxoSmithKline and was approved by the U.S. Food and Drug Administration (FDA) in 2007 to treat a specific type of breast cancer.

Lapatinib is already on the market in China, but it has not yet been included in medical insurance. Patients can purchase it domestically at a price of around 5,000 to 6,000 yuan. Please consult the local hospital pharmacy for specific prices. There are original lapatinib drugs and generic drugs abroad. The original drug is cheaper than the original drug in Türkiye, which costs more than 2,000 yuan. Generic drugs include Indian generic drugs and Bangladeshi generic drugs, and the price is around a few hundred yuan. The ingredients of domestic original drugs, foreign original drugs and generic drugs are basically the same.

Lapatinib is a targeted therapy drug that mainly works by inhibiting some key signaling pathways in breast cancer cells. Specifically, it inhibits the activity of HER2 and EGFR (epidermal growth factor receptor) proteins, which are overexpressed in some cases of breast cancer.

Lapatinib is commonly used to treat HER2 positive breast cancer. HER2positive breast cancer is a subtype of breast cancer in which tumor cells express too much of the HER2 receptor. Lapatinib is often used with other drugs such as tamoxifen or exemestane to treat advanced or metastatic breast cancer.

Lapatinib is usually taken as an oral tablet. Dosage and treatment regimens will vary based on the patient's specific condition and usually require a physician to prescribe and monitor the patient's response. The use of lapatinib may cause a range of side effects, including diarrhea, skin rash, hand-foot syndrome (redness, swelling and pain in the hands and feet), fatigue, etc. Some patients may experience more severe side effects and require close monitoring and management during use. Patients need to closely follow the doctor's recommendations and prescriptions while using lapatinib, and undergo regular examinations to ensure the effectiveness and safety of the drug. Additionally, lapatinib may interact with other medications, so patients should inform their doctor about all medications and supplements they are taking.